SLG
RMD icon

Stanley-Laman Group’s ResMed RMD Stock Holding History

Stanley-Laman Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,057
Closed -$222K – 282
2022
Q2 		$222K Sell
1,057
-215
-17% -$45.8K 0.04% 247
2022
Q1 		$308K Buy
+1,272
New +$308K 0.04% 235
2015
Q2 		– Sell
-9,717
Closed -$697K – 314
2015
Q1 		$697K Sell
9,717
-1,622
-14% -$105K 0.13% 173
2014
Q4 		$636K Sell
11,339
-118
-1% -$6.16K 0.12% 179
2014
Q3 		$564K Hold
11,457
– – 0.11% 186
2014
Q2 		$580K Hold
11,457
– – 0.11% 186
2014
Q1 		$512K Buy
11,457
+3,494
+44% +$157K 0.09% 194
2013
Q4 		$375K Buy
+7,963
New +$403K 0.08% 152

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Stanley-Laman Group's RMD Position: Q3 2022 in Review

Stanley-Laman Group sold out of ResMed (RMD) in Q3 2022, closing a stake of 1,057 shares — an estimated $222K sold.

Stanley-Laman Group first reported a position in RMD in Q4 2013 and held it in 8 quarters. The position peaked at $697K in Q1 2015. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Stanley-Laman Group reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 1,057 ResMed shares in Q3 2022, an estimated $222K.
  • Stanley-Laman Group first reported a position in ResMed in Q4 2013 and held it in 8 quarters.
  • Stanley-Laman Group's ResMed position peaked at $697K in Q1 2015.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Stanley-Laman Group's 13F filing for Q3 2022, filed 18 Oct 2022.